PDS Biotechnology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PDSB and other ETFs, options, and stocks.About PDSB
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection.
PDSB Key Statistics
Stock Snapshot
As of today, PDS Biotechnology(PDSB) shares are valued at $0.92. The company's market cap stands at 50.36M, with a P/E ratio of -1.12.
On 2025-12-16, PDS Biotechnology(PDSB) shares started trading at $1.00, with intraday highs of — and lows of —.
Trading volume for PDS Biotechnology(PDSB) stock has reached 0, versus its average volume of 791.29K.
Over the past 52 weeks, PDS Biotechnology(PDSB) stock has traded between a high of $2.20 and a low of $0.70.
Over the past 52 weeks, PDS Biotechnology(PDSB) stock has traded between a high of $2.20 and a low of $0.70.
PDSB News
TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...
PDS Biotechnology (PDSB) announced that the Japan Patent Office has issued Patent No. 7783866 for PDS0101 granting broad composition of matter and methods of us...